Amgen Inc. buy Royal Bank of Canada
Start price
26.09.24
/
50%
€284.10
Target price
26.09.25
€324.86
Performance (%)
-17.65%
End price
27.09.25
€233.95
Summary
This prediction ended on 27.09.25 with a price of €233.95. The prediction for Amgen Inc. disappointed with a performance of -17.65%. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €9.15 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | 4.016% | 4.016% | 11.450% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $362.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten